The effects for PM2.5 exposure on non-small-cell lung cancer induced motility and proliferation

被引:41
|
作者
Yang, Biao [1 ]
Chen, Dongmei [2 ]
Zhao, Hui [2 ]
Xiao, Chunling [2 ]
机构
[1] Liaoning Univ Tradit Chinese Med, Basic Discipline Chinese & Western Integrat, Shenyang 110032, Liaoning, Peoples R China
[2] Shenyang Med Coll, Key Lab Environm Pollut & Microecol, 146 Huanghe North St, Shenyang 110034, Liaoning Provin, Peoples R China
来源
SPRINGERPLUS | 2016年 / 5卷
基金
中国国家自然科学基金;
关键词
Cell proliferation; Migration; Non-small cell lung cancer; PM2.5; FINE PARTICULATE MATTER; LONG-TERM EXPOSURE; AIR-POLLUTION; MORTALITY; APOPTOSIS; STRESS;
D O I
10.1186/s40064-016-3734-8
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Increasing urbanization and associated air pollution, including elevated levels of particulate matter (PM), are strongly correlated with the development of various respiratory diseases. In particular, PM2.5 has been implicated in promoting lung cancer initiation, growth and progression. Cell migration and proliferation are crucial for the progression of cancer. However, the molecular signatures and biological networks representing the distinct and shared features of non-small cell lung cancer (NSCLC) after PM2.5 exposure are unknown. Results: Functional assays demonstrated higher proliferation, migration and invasion of cancer cells stimulated with PM2.5. To investigate the complicated mechanisms, we performed global transcriptome profiling of the A549 cell line. Particularly, transcriptome sequencing revealed invasive characteristics reminiscent of cancer cells. By comparing the transcriptomes, we identified distinct molecular signatures and cellular processes defining the invasive and proliferative properties of PM2.5-exposed cells, respectively. Interestingly, under the PM2.5-stimulated condition, the A549 and H1299 cells strengthened obviously properties in motility and proliferation. Based on the network model reconstructing the shared protein-protein interactions, we selected the two most up-regulated genes, interleukin-1 beta (IL1 beta) and matrix metalloprotease 1 (MMP1), as key regulators responsible for the effects of PM2.5 exposure. Notably, IL1 beta and MMP1 expression was elevated in independent assays, which was further enhanced by PM2.5. Conclusion: Taken together, our systems approach to investigating PM2.5 exposure provides a basis to identify key regulators responsible for the pathological features of NSCLC.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Evaluation of Outdoor Air Pollution Exposure (PM2.5) In Female Non-smoking Lung Cancer Patients
    Myers, R. L.
    Tammemagi, M. C.
    Brauer, M.
    Atkar-Khattra, S.
    Buncio, A. Dy
    Yee, J.
    Melosky, B.
    Lam, S.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S34 - S34
  • [42] Erlotinib in non-small-cell lung cancer
    Gridelli, Cesare
    Rossi, Antonio
    Malone, Paolo
    Colantuoni, Giuseppe
    Del Gaizo, Filomena
    Ferrara, Carmine
    Nicolella, Dario
    Guerriero, Ciro
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (15) : 2579 - 2592
  • [43] Osimertinib for non-small-cell Lung Cancer
    Alakus, Hakan
    Zander, Thomas
    Bruns, Christiane
    ONKOLOGE, 2018, 24 (02): : 174 - 176
  • [44] Adagrasib in Non-Small-Cell Lung Cancer
    Kotecha, Rupesh
    Sahgal, Arjun
    Mehta, Minesh P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (13): : 1238 - 1239
  • [45] Non-Small-Cell Lung Cancer: Then and Now
    Schiller, Joan H.
    Gandara, David R.
    Goss, Glenwood D.
    Vokes, Everett E.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (08) : 981 - 983
  • [46] Chemotherapy for non-small-cell lung cancer
    Satoh, H
    Sekizawa, K
    LANCET, 2001, 358 (9289): : 1270 - 1271
  • [47] Ifosfamide in non-small-cell lung cancer
    Rosell, R
    Martin, C
    Balaña, C
    ANNALS OF ONCOLOGY, 1999, 10 : 25 - 28
  • [48] Cetuximab in non-small-cell lung cancer
    Pirker, Robert
    Filipits, Martin
    TRANSLATIONAL LUNG CANCER RESEARCH, 2012, 1 (01) : 54 - 60
  • [49] Cancer vaccines for non-small-cell lung cancer
    Palma, M.
    Choudhury, A.
    Mellstedt, H.
    MINERVA CHIRURGICA, 2009, 64 (06) : 643 - 653
  • [50] Treatment of non-small-cell lung cancer
    Lavolé, A
    Blanchon, F
    Breton, JL
    Milleron, B
    REVUE DES MALADIES RESPIRATOIRES, 2004, 21 (01) : 175 - 178